On most nights, Jonah counts his antiretroviral pills to stop his HIV disease from multiplying before he counts his earnings.

The National Agency for Food and Drug Administration and Control (NAFDAC) has raised the alarm over the circulation of ...

Rose Parade Grand Marshal Earvin Magic Johnson like to team up, starting when playing basketball, to businesses and charities ...

Elon Musk has launched another sharp public attack on Bill Gates, calling him a “liar” over claims linking USAID funding cuts ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc.

The year was marked by hospital detentions, drug stock-outs, preventable deaths, and the hopelessness of a workforce pushed ...

Mrs Gifty Addo-Tetebo, Eastern Regional Coordinator for STI /HIV and AIDS at the Regional Health Directorate, has entreated ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Two phase III studies of setrusumab, Orbit and Cosmic, for treating brittle bones have failed and left the developers floundering on Wall Street. Neither of Ultragenyx Pharmaceutical Inc. and Mereo ...

The Herald (Top Stories) Trust Freddy Herald Correspondent GOVERNMENT has lauded the National Aids Council (NAC) for its stringent adherence to public finance management and corporate governance, ...

The 2024 NYC HIV report shows a 5.4% increase in new cases, with Black and Latino communities facing the sharpest impact.

On December 16, Julian Emanuel, Senior Managing Director at Evercore ISI, shared his outlook on the equity market and the ...